A new study has helped solve the mystery of how dysfunctional chromosome folding leads to cancer.
Yearly Archives: 2020
The elevated expression of a gene called LY6K was correlated with increased cancer cell growth and resistance to radiation therapy in glioblastoma, according to a recent Northwestern Medicine study.
Northwestern Medicine has enrolled its first participants in a new international clinical drug trial for COVID-19, testing remdesivir, a novel anti-viral drug developed to treat Ebola, and which has also shown antiviral activity in coronaviruses.
A new method of delivering radiation during whole brain radiotherapy could reduce neurotoxicity without compromising effectiveness, according to a new study.
A special COVID-19 testing team has been put in place at Northwestern, with the goal of at least quadrupling the number of tests processed at Northwestern Medicine hospitals — from about 90 per day to more than 350 per day — and in the process, greatly reducing test result turnaround times.
Nicholas Soulakis, PhD, is taking a leave of absence from the medical school to work as an epidemiologist in the Illinois Department of Public Health Office of Policy, Planning and Statistics.
Gary Noskin, MD, professor of Medicine in the Division of Infectious Diseases and chief medical officer at Northwestern Memorial Hospital, answers questions about how Northwestern’s clinical research team is responding to the COVID-19 pandemic.
More than 110 faculty, staff, students, and trainees have come together to collaborate and work closely with Chicago hospitals and communities to forecast the spread of the COVID-19 pandemic, predict the outcome of public health interventions and share resources for containing the disease.
Northwestern University Feinberg School of Medicine students have organized a volunteer effort among medical students and graduate students to help support health care workers, older community members at higher risk for COVID-19 and working parents during the pandemic.
Risk of relapse for chronic myeloid leukemia patients may be reduced through drug combination after discontinuing initial therapy, according to a Northwestern Medicine study published in the journal Leukemia.